Identillect’s Delivery Trust® Implemented by Jellyfish Health for Secure Communications for HIPAA Compliance
Delivery Trust® Email Encryption Solution Provides HIPAA Compliant Secure Communications to Jellyfish Health, a Patient Experience Software Provider
IRVINE, Calif., July 20, 2018 (GLOBE NEWSWIRE) -- Identillect Technologies Corp. (the "Company" or "Identillect") (TSX-V:ID) (OTCQB:IDTLF) (Frankfurt:8ID), a trusted leading provider of compliant email security, announced today Jellyfish Health, a HIPAA compliant software company that provides patients the ultimate streamlined experience during their medical visit which ensures time savings and a positive patient experience.
Jellyfish Health offers a seamless, integrated patient experience through numerous interactions across multiple touch points for practices, urgent cares, and health systems. Jellyfish Health changes how providers interact with their patients and the medical community, enhancing the healthcare experience for patients and increases satisfaction. Jellyfish Health helps healthcare providers emphasize how their patients are valued, through streamlining the process, creating better time management, which develops greater patient loyalty.
Dave Dyell, CEO of Jellyfish Health states, “Jellyfish Health provides advanced patient experience software to major healthcare providers throughout the United States, and secure communication is an essential aspect of our business model. We are proud to integrate Delivery Trust to expand secure communication for the medical organizations we service.”
As continued growth occurs in healthcare technology there is a greater need to utilize advanced software to accommodate growth ensuring maximum efficiency and security. The anticipated growth is to increase almost creating significant demand for software companies like Identillect and Jellyfish Health. The global market for healthcare market should reach nearly at a compound annual growth rate (CAGR) of 15.8%.
Todd Sexton, CEO of Identillect Technologies comments, “We are extremely pleased to integrate Delivery Trust email security into Jellyfish Health and secure their communication needs. As with Delivery Trust, Jellyfish Health fills a significant need in the medical community and we see both software offerings expanding in the months to come.”
The Health Insurance Portability and Accountability Act (HIPAA) is legislation focused on data privacy and security for medical information. As a result of increasing cybersecurity threats, the rules surrounding internet security were enhanced to protect confidential patient information. In a recent , In the past 12 months, 75.7% of respondents said they had experienced a recent significant security incident, 61.4% of respondents said email was the main initial point of compromise. As this problem continues to grow, it is critical business in all industries and especially within HIPAA, where there is an inordinate amount of personal data, utilize encryption.
On Behalf of the Board of Directors of:
IDENTILLECT TECHNOLOGIES CORP.
Todd Sexton
Chief Executive Officer
Tel: (949) 468-7878
Email:
About Identillect
Identillect Technologies is the leading provider of email encryption service Delivery Trust®, empowering enterprises of all sizes to protect their business and their client’s critical information against cyber security attacks.
Delivery Trust® is an award-winning, multi-platform plug-in, which gives users complete control of their emails, for one low price. One simple integration complies with all regulations and most importantly provides peace of mind.
For more information, or your free trial, please visit
About Jellyfish Health
Founded in 2014 and based in Panama City, Florida, Jellyfish Health transforms the patient experience through actionable data, driving greater transparency at each step of the patient journey. Its advanced technology enables healthcare and provider organizations to optimize patient scheduling, wait time updates, appointment status notifications and overall patient volume.
For more information, or your free trial, please visit
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
